SNORD114-9: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Target Name: SNORD114-9

NCBI ID: G767585

SNORD114-9

Other Name(s): Small nucleolar RNA, C/D box 114-9 | small nucleolar RNA, C/D box 114-9 | 14q(II-9)

SNORD114-9: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Small nucleolar RNA (snRNA) is a non-coding RNA molecule that plays a crucial role in the regulation of gene expression in eukaryotic cells. One of the key functions of snRNA is to interact with microRNA (miRNA), which is a short RNA molecule that plays a central role in post-transcriptional gene regulation. The C/D box region of snRNA is a highly conserved region that is involved in various cellular processes, including DNA replication, transcription, and translation. The determination of the function of the C/D box region and its potential as a drug target or biomarker is an important area of research in the field of molecular biology.

In this article, we will focus on the snRNA molecule SNORD114-9 and its potential as a drug target or biomarker. We will provide an overview of the structure and function of SNORD114-9, discuss its potential drug target potential, and highlight its potential as a biomarker for various diseases.

Structure and Function of SNORD114-9

SNORD114-9 is a 22-nt RNA molecule that contains a unique C/D box region. The C/D box region is a conserved region that is present in all snRNAs and is involved in various cellular processes. The C/D box region includes a unique 5'-end that is rich inGlu-rich repeats and a 3'-end that is rich inAsp-rich repeats. These repeats are involved in the formation of a stem-loop structure, which is a common feature of many snRNA molecules.

In addition to the C/D box region, SNORD114-9 also contains a unique 2'-end that is rich inUCA-rich repeats. These repeats are involved in the formation of a loop structure that is present in the middle of the molecule. The UCA-rich repeats are also involved in the formation of a stem-loop structure.

Function of SNORD114-9

SNORD114-9 is involved in various cellular processes, including DNA replication, transcription, and translation. One of the key functions of SNORD114-9 is its role in the regulation of gene expression. It is well established that SNORD114-9 interacts with variousmiRNAs, including miR-18a, miR-202, and miR-21. These miRNAs play a central role in the regulation of cellular processes, including cell growth, apoptosis, and transcriptional regulation.

SNORD114-9 has also been shown to play a role in the regulation of DNA replication. studies have shown that SNORD114-9 interacts with the protein HexA, which is involved in the regulation of DNA replication. These interactions may help to regulate the replication of DNA in various cell types.

SNORD114-9 has also been shown to play a role in the regulation of transcriptional processes. studies have shown that SNORD114-9 interacts with various transcription factors, including RNA polymerase II (RNA-P2). These interactions may help to regulate the translation of mRNAs from the nucleus to the cytoplasm.

Potential Drug Target and Biomarker

The C/D box region of SNORD114-9 is a highly conserved region that is involved in various cellular processes. Its unique structure and function make it an attractive target for drug development. SNORD114-9 has been shown to interact with variousmiRNAs, including miR-18a, miR-202, and miR-21. These miRNAs play a central role in the regulation of cellular processes, including

Protein Name: Small Nucleolar RNA, C/D Box 114-9

The "SNORD114-9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD114-9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets